Cargando…
Why clinical trial outcomes fail to translate into benefits for patients
Clinical research should ultimately improve patient care. For this to be possible, trials must evaluate outcomes that genuinely reflect real-world settings and concerns. However, many trials continue to measure and report outcomes that fall short of this clear requirement. We highlight problems with...
Autores principales: | Heneghan, Carl, Goldacre, Ben, Mahtani, Kamal R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5348914/ https://www.ncbi.nlm.nih.gov/pubmed/28288676 http://dx.doi.org/10.1186/s13063-017-1870-2 |
Ejemplares similares
-
Why do antioxidants fail to provide clinical benefit?
por: Warnholtz, Ascan, et al.
Publicado: (2000) -
Why COVID-19 modelling of progression and prevention fails to translate to the real-world
por: Heneghan, Carl J., et al.
Publicado: (2022) -
Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process
por: Heneghan, Carl J, et al.
Publicado: (2017) -
Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports
por: Hodkinson, Alexander, et al.
Publicado: (2021) -
COMPare: Qualitative analysis of researchers’ responses to critical correspondence on a cohort of 58 misreported trials
por: Goldacre, Ben, et al.
Publicado: (2019)